1. Home
  2. DY vs RGEN Comparison

DY vs RGEN Comparison

Compare DY & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dycom Industries Inc.

DY

Dycom Industries Inc.

HOLD

Current Price

$273.80

Market Cap

9.3B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$190.50

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DY
RGEN
Founded
1969
1981
Country
United States
United States
Employees
N/A
2000
Industry
Water Sewer Pipeline Comm & Power Line Construction
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
10.0B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
DY
RGEN
Price
$273.80
$190.50
Analyst Decision
Strong Buy
Buy
Analyst Count
10
12
Target Price
★ $425.30
$167.67
AVG Volume (30 Days)
617.4K
★ 882.0K
Earning Date
05-20-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
20.71
★ 286.96
EPS
★ 6.81
0.24
Revenue
N/A
★ $141,236,000.00
Revenue This Year
$30.96
$14.30
Revenue Next Year
$9.49
$14.52
P/E Ratio
★ $39.96
$794.38
Revenue Growth
N/A
★ 35.10
52 Week Low
$271.87
$100.99
52 Week High
$566.47
$192.49

Technical Indicators

Market Signals
Indicator
DY
RGEN
Relative Strength Index (RSI) 30.72 68.29
Support Level N/A $158.15
Resistance Level $309.48 N/A
Average True Range (ATR) 10.92 6.10
MACD 2.31 1.44
Stochastic Oscillator 8.10 93.48

Price Performance

Historical Comparison
DY
RGEN

About DY Dycom Industries Inc.

Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. The company has two reporting segments: Communications and Building Systems. The Communications segment provides specialty contracting services, including program management, planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services for telecommunications and digital infrastructure providers. The Building Systems segment specializes in providing comprehensive building infrastructure solutions, including electrical, energy management, security, and fire safety systems for data centers and other critical facilities. The firm generates key revenue from Communications.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: